Alkerms Pharmaceuticals Private Limited
About Alkerms Pharmaceuticals Private Limited
Data last updated:
Alkerms Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 18 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2015PTC284193. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Ravi Verma and Dipti Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 164 – B Gali No. 5 Virendra Nagar Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹12,690, a decline of 90% compared to the previous year. For the same year it recorded a net profit of ₹815 (net margin 6.4%) and EBITDA of ₹1,041 (EBITDA margin 8.2%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alkerms Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressWz – 164 – B Gali No. 5 Virendra Nagar Janakpuri, New Delhi, Delhi, India – 110058
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Alkerms Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alkerms Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Alkerms Pharmaceuticals Private Limited, buy the company report.
Financials of Alkerms Pharmaceuticals Private Limited
FY 2025 filings availableAlkerms Pharmaceuticals Private Limited reported revenue of ₹12,690 (down 90% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 90% fall in the latest year. EBITDA fell 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,041 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹815 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alkerms Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alkerms Pharmaceuticals Private Limited
Alkerms Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Verma | Director | 18 Aug 2015 | 11 Years 2 Months | Current |
| Dipti Verma | Director | 24 Oct 2016 | 9 Years 11 Months | Current |
Auditor
Alkerms Pharmaceuticals Private Limited is audited by PERIWAL & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PERIWAL & CO | FY 2017 | PERIWAL & CO |
Shareholding
The shareholding of Alkerms Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alkerms Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alkerms Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alkerms Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alkerms Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Alkerms Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alkerms Pharmaceuticals Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Ashish Suman ceased to be Director on 17 May 2017.
Frequently asked questions
Alkerms Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 18 August 2015 (11+ years old) and is registered under CIN U74140DL2015PTC284193.
Alkerms Pharmaceuticals has 2 current directors:
- Ravi Verma - Director
- Dipti Verma - Director
The latest financial statements of Alkerms Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
No. Alkerms Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Alkerms Pharmaceuticals is U74140DL2015PTC284193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alkerms Pharmaceuticals was incorporated on 18 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Ashish Suman ceased to be Director on 17 May 2017. Deepak Sahay ceased to be Director on 24 Oct 2016. Dipti Verma was appointed as Director on 24 Oct 2016. Alkerms Pharmaceuticals has 4 board changes on record in total.
The registered office of Alkerms Pharmaceuticals is at Wz – 164 – B Gali No. 5 Virendra Nagar Janakpuri, New Delhi, Delhi, India – 110058.
Alkerms Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Alkerms Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.